D-EYE, Srl

15/10/2022

Note the "median" averages. Good to see.

The third quarter of 2022 saw a 40% drop in global health innovation funding from the previous quarter, continuing a year-long trend of…

13/03/2021

Excellent simple discussion on the differences between the various Covid 19 vaccines now be administered.

Yes, all of the COVID-19 vaccines are very good. No, they’re not all the same.

24/02/2021

✅ Wow! The D-EYE is featured in the latest issue of Ophthalmology Times. Read the article and let us know your thoughts.

Our Feb. 15 issue is out! See the digital edition here: https://buff.ly/3u4BBMW

28/01/2021

Artificial Intelligence is a consistent part of See Far H2020 European Project that aims to design and validate a digitally enabled adaptive solution supporting ageing workforce with vision loss. The See Far is a low-cost, unobtrusive solution that can be used in the working and living environment and on the move.
Read more here: https://www.see-far.eu/artificial-intelligence-in-medicine/
Subscribe our newsletter or contact us (info@see-far.eu) to know all the progress and stay up-to-date: https://www.see-far.eu/newsletter/

See Far is a digitally enabled adaptive solution supporting ageing workforce with vision deficiencies, an age-related condition, to remain actively involved in professional life, helping them to sustain and renew their work and personal life – related skills and support an independent active and h...

21/12/2020

⭕️ Artificial Intelligence for the See Far Project ⭕️

We have seen it in fictional TV-series, movies but also in futuristic literature such as Isaac Asimov’s novels. Artificial Intelligence has unimaginable potential and in a couple of years, it will revolutionize most of the aspects of our daily lives. In the latest years, AI is turning into a refer...

19/12/2020

We are getting closer....

We strongly believe that only digital health can bring healthcare into the 21st century and make patients the point-of-care.

22/07/2020

📌 University of Bonn and Uniklinik Bonn tested the D-EYE in this interesting comparison study about diabetic retinopathy screenings using smartphone-based fundus imaging.

American Academy of Ophthalmology

Early detection and treatment can prevent irreversible blindness from diabetic retinopathy (DR), which is the leading cause of visual impairment among working-aged adults worldwide. Some 80% of affected persons live in low- and middle-income countries, yet lack of resources has largely prevented DR....

15/07/2020

📌 This case study details 5 patients with nonremitting conjunctivitis that was the sole presenting sign and symptom of COVID-19.

American Academy of Ophthalmology

This case study details 5 patients with nonremitting conjunctivitis that was the sole presenting sign and symptom of COVID-19.

08/07/2020

⭕️ A rapid-fire view of 2019’s best innovations in optometry- that stood out the most to ODs.

Optometry Times

A rapid-fire view of 2019’s best innovations in optometry- that stood out the most to ODs.

03/07/2020

📌 Is AI tomorrow’s answer to screening, management, and treatment of glaucoma?

The Ophthalmologist

Is artificial intelligence tomorrow’s answer to screening, management, and treatment? Experts weigh in.

29/06/2020

✅ A huge thanks to The Medical Futurist for this amazing review and test of the D-EYE Smartphone-Based Retinal Imaging System! We are sure that ophthalmology can really profit from telemedicine and innovative devices.

We strongly believe that only digital health can bring healthcare into the 21st century and make patients the point-of-care.

26/06/2020

📌 Study published in the journal of the American Academy of Ophthalmology lays important groundwork for an automated system that can detect diabetic eye disease